Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mucositis × pegaspargase × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Leukemia 43 Lymphoma, Extranodal NK-T-Cell 18 Burkitt Lymphoma 15 Lymphoma 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia, Biphenotypic, Acute 7 Recurrence 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 3 Lymphohistiocytosis, Hemophagocytic 3 Leukemia, T-Cell 3 Leukemia, Myeloid, Acute 3 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Epstein-Barr Virus Infections 2 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Multiple Myeloma 1 Mucositis 1 Lymphoproliferative Disorders 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Down Syndrome 1 Dendritic Cell Sarcoma, Interdigitating 1 Blast Crisis 1

Interventions

Radiotherapy 6 Cisplatin 5 Radiation 4 Injections 4 Fibroblast Growth Factor 7 4 Propolis 3 Morphine 3 Low-Level Light Therapy 3 Drug Therapy 3 angiotensin I (1-7) 2 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Water 2 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Methotrexate 2 Melphalan 2 Lidocaine 2 Leucovorin 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Gabapentin 2 Fluorouracil 2 Diphenhydramine 2 Cryotherapy 2 Amifostine 2 tempol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡